117 related articles for article (PubMed ID: 10488977)
1. Variable genetic alterations and survival in head and neck cancer.
Gleich LL; Li YQ; Wang X; Stambrook PJ; Gluckman JL
Arch Otolaryngol Head Neck Surg; 1999 Sep; 125(9):949-52. PubMed ID: 10488977
[TBL] [Abstract][Full Text] [Related]
2. [Improved prognostic assessment of head-neck carcinomas by new genetic markers].
Bockmühl U; Küchler I; Petersen I
HNO; 2000 Jun; 48(6):451-6. PubMed ID: 10929226
[TBL] [Abstract][Full Text] [Related]
3. Correlation of numerical aberrations of chromosomes X and 11 and poor prognosis in squamous cell carcinomas of the head and neck.
Xie X; Clausen OP; Boysen M
Arch Otolaryngol Head Neck Surg; 2006 May; 132(5):511-5. PubMed ID: 16702567
[TBL] [Abstract][Full Text] [Related]
4. p53 and cyclin D1 as prognostic factors in squamous cell carcinoma of the larynx.
Vielba R; Bilbao J; Ispizua A; Zabalza I; Alfaro J; Rezola R; Moreno E; Elorriaga J; Alonso I; Baroja A; de la Hoz C
Laryngoscope; 2003 Jan; 113(1):167-72. PubMed ID: 12514403
[TBL] [Abstract][Full Text] [Related]
5. Cyclin D1 amplification and p16(MTS1/CDK4I) deletion correlate with poor prognosis in head and neck tumors.
Namazie A; Alavi S; Olopade OI; Pauletti G; Aghamohammadi N; Aghamohammadi M; Gornbein JA; Calcaterra TC; Slamon DJ; Wang MB; Srivatsan ES
Laryngoscope; 2002 Mar; 112(3):472-81. PubMed ID: 12148857
[TBL] [Abstract][Full Text] [Related]
6. The loss of heterozygosity in retinoblastoma and p53 suppressor genes as a prognostic indicator for head and neck cancer.
Gleich LL; Li YQ; Biddinger PW; Gartside PS; Stambrook PJ; Pavelic ZP; Gluckman JL
Laryngoscope; 1996 Nov; 106(11):1378-81. PubMed ID: 8914904
[TBL] [Abstract][Full Text] [Related]
7. Incorporation of Next-Generation Sequencing into Routine Clinical Care to Direct Treatment of Head and Neck Squamous Cell Carcinoma.
Chau NG; Li YY; Jo VY; Rabinowits G; Lorch JH; Tishler RB; Margalit DN; Schoenfeld JD; Annino DJ; Goguen LA; Thomas T; Becker H; Haddad T; Krane JF; Lindeman NI; Shapiro GI; Haddad RI; Hammerman PS
Clin Cancer Res; 2016 Jun; 22(12):2939-49. PubMed ID: 26763254
[TBL] [Abstract][Full Text] [Related]
8. Comprehensive genomic profiling of head and neck squamous cell carcinoma reveals FGFR1 amplifications and tumour genomic alterations burden as prognostic biomarkers of survival.
Dubot C; Bernard V; Sablin MP; Vacher S; Chemlali W; Schnitzler A; Pierron G; Ait Rais K; Bessoltane N; Jeannot E; Klijanienko J; Mariani O; Jouffroy T; Calugaru V; Hoffmann C; Lesnik M; Badois N; Berger F; Le Tourneau C; Kamal M; Bieche I
Eur J Cancer; 2018 Mar; 91():47-55. PubMed ID: 29331751
[TBL] [Abstract][Full Text] [Related]
9. Microsatellite alterations in african americans with head and neck cancer.
Yoo GH; Nguyen NX; Du W; Schwartz AG; Land S; Lin HS; Kewson D; Murphy LL; Cilluffo D; Ensley JF; Tainsky MA
Laryngoscope; 2004 Sep; 114(9):1619-24. PubMed ID: 15475792
[TBL] [Abstract][Full Text] [Related]
10. Overexpression of cyclin D1 indicates a poor prognosis in squamous cell carcinoma of the head and neck.
Michalides RJ; van Veelen NM; Kristel PM; Hart AA; Loftus BM; Hilgers FJ; Balm AJ
Arch Otolaryngol Head Neck Surg; 1997 May; 123(5):497-502. PubMed ID: 9158396
[TBL] [Abstract][Full Text] [Related]
11. Allelic loss at chromosomes 3p, 8p, 13q, and 17p associated with poor prognosis in head and neck cancer.
Li X; Lee NK; Ye YW; Waber PG; Schweitzer C; Cheng QC; Nisen PD
J Natl Cancer Inst; 1994 Oct; 86(20):1524-9. PubMed ID: 7932807
[TBL] [Abstract][Full Text] [Related]
12. [Prognostic significance of cell-cycle regulatory proteins for outcome after primary radiochemotherapy in patients with advanced head and neck cancer].
Haas S; Bosch FX; Klein-Kühne W; Nollert J; Rudat V; Conradt C; Dietz A
HNO; 1999 Sep; 47(9):777-86. PubMed ID: 10525606
[TBL] [Abstract][Full Text] [Related]
13. Microsatellite Alterations With Allelic Loss at 9p24.2 Signify Less-Aggressive Colorectal Cancer Metastasis.
Koi M; Garcia M; Choi C; Kim HR; Koike J; Hemmi H; Nagasaka T; Okugawa Y; Toiyama Y; Kitajima T; Imaoka H; Kusunoki M; Chen YH; Mukherjee B; Boland CR; Carethers JM
Gastroenterology; 2016 Apr; 150(4):944-55. PubMed ID: 26752111
[TBL] [Abstract][Full Text] [Related]
14. Prognostic value of CXCL12 and CXCR4 in inoperable head and neck squamous cell carcinoma.
Rave-Fränk M; Tehrany N; Kitz J; Leu M; Weber HE; Burfeind P; Schliephake H; Canis M; Beissbarth T; Reichardt HM; Wolff HA
Strahlenther Onkol; 2016 Jan; 192(1):47-54. PubMed ID: 26374452
[TBL] [Abstract][Full Text] [Related]
15. Gene therapy for head and neck cancer.
Gleich LL
Laryngoscope; 2000 May; 110(5 Pt 1):708-26. PubMed ID: 10807351
[TBL] [Abstract][Full Text] [Related]
16. [Genetic screening of head-neck carcinomas using comparative genomic hybridization (CGH)].
Bockmühl U; Petersen I; Schwendel A; Dietel M
Laryngorhinootologie; 1996 Jul; 75(7):408-14. PubMed ID: 8924169
[TBL] [Abstract][Full Text] [Related]
17. [p53 mutations/p53 protein overexpression. Differential significance for the progression of head-neck carcinomas].
Bosch FX; Homann N; Conradt C; Dietz A; Erber R
HNO; 1999 Sep; 47(9):833-48. PubMed ID: 10525616
[No Abstract] [Full Text] [Related]
18. Genomic amplification of Fanconi anemia complementation group A (FancA) in head and neck squamous cell carcinoma (HNSCC): Cellular mechanisms of radioresistance and clinical relevance.
Hess J; Unger K; Orth M; Schötz U; Schüttrumpf L; Zangen V; Gimenez-Aznar I; Michna A; Schneider L; Stamp R; Selmansberger M; Braselmann H; Hieber L; Drexler GA; Kuger S; Klein D; Jendrossek V; Friedl AA; Belka C; Zitzelsberger H; Lauber K
Cancer Lett; 2017 Feb; 386():87-99. PubMed ID: 27867017
[TBL] [Abstract][Full Text] [Related]
19. [Investigations to the influence of tumor supressor gene p16 inactivation on the prognosis of head and neck squamous cell carcinoma].
Koscielny S; V Eggeling F; Dahse R
Laryngorhinootologie; 2004 Jun; 83(6):374-80. PubMed ID: 15197677
[TBL] [Abstract][Full Text] [Related]
20. Classic and molecular cytogenetic analyses reveal chromosomal gains and losses correlated with survival in head and neck cancer patients.
Bérgamo NA; da Silva Veiga LC; dos Reis PP; Nishimoto IN; Magrin J; Kowalski LP; Squire JA; Rogatto SR
Clin Cancer Res; 2005 Jan; 11(2 Pt 1):621-31. PubMed ID: 15701849
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
